NIH to evaluate remdesivir treatment for COVID during pregnancy

WASHINGTON (NEWS10) — The National Institutes of Health (NIH) is funding a study into the effects of prescription remdesivir on those who are both pregnant and COVID-positive. Called “IMPAACT 2032,” the study, conducted at 17 sites in the U.S., will examine how pregnant people metabolize and digest the drug, and whether it poses side effects. […]

Study will evaluate remdesivir for COVID-19 in pregnant women

Efficacy Data for COVID-19

COVID, Free Full-Text

13 Things To Know About Paxlovid, the Latest COVID-19 Pill > News

Frontiers Mortality Benefit of Remdesivir in COVID-19: A

Remdesivir: A Review of Its Discovery and Development Leading to

Federal Response to COVID-19: Therapeutics CIG

Caring for High-Risk Ambulatory Adult Patients

Remdesivir against COVID-19 and Other Viral Diseases

Evaluation & Management of COVID-19 in Pregnancy

Remdesivir for the treatment of hospitalized patients with severe

Clinical outcomes of hospitalized COVID-19 patients treated with